Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.00026 | 1 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.00013 | 1 |